Smith & Nephew (SNN) Shares Outstanding (Weighted Average) (2009 - 2025)
Smith & Nephew (SNN) posted Shares Outstanding (Weighted Average) of $175.0 million for Q4 2025, little changed on a QoQ basis from $175.0 million in Q4 2024, and little changed year-over-year from $175.0 million in Q4 2024.
Smith & Nephew (SNN) has 11 years of Shares Outstanding (Weighted Average) data on file, last reported at $175.0 million in Q4 2025.
- In Q4 2025, Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $175.0 million; the TTM figure through Dec 2025 stood at $175.0 million (changed 0.0% YoY), while the FY2025 annual figure was $175.0 million, changed 0.0% from the prior year.
- Shares Outstanding (Weighted Average) held at $175.0 million in Q4 2025, from $175.0 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $872.0 million in Q4 2022 and bottomed at $175.0 million in Q4 2024.
- A 5-year average of $454.0 million and a median of $177.0 million in 2021 frame the typical range for Shares Outstanding (Weighted Average).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) surged 392.66% — and 2024, when it sank 79.91%.
- Year by year, Shares Outstanding (Weighted Average) stood at $177.0 million in 2021, then jumped by 392.66% to $872.0 million in 2022, then slipped by 0.11% to $871.0 million in 2023, then sank by 79.91% to $175.0 million in 2024, then changed by 0.0% to $175.0 million in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $175.0 million (Q4 2025), $175.0 million (Q4 2024), and $871.0 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Smith & Nephew | 5.16 Bn | 4.58 Bn | - | 175.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 175.00 Mn |
| Jun 28, 2025 | 175.00 Mn |
| Dec 31, 2024 | 175.00 Mn |
| Jun 29, 2024 | 175.00 Mn |
| Dec 31, 2023 | 871.00 Mn |
| Dec 31, 2022 | 872.00 Mn |
| Dec 31, 2021 | 177.00 Mn |
| Dec 31, 2020 | 177.00 Mn |
| Jun 30, 2020 | 177.00 Mn |
| Dec 31, 2019 | 177.00 Mn |
| Jun 29, 2019 | 177.00 Mn |
| Dec 31, 2018 | 873.00 Mn |
| Jun 30, 2018 | 178.00 Mn |
| Dec 31, 2017 | 874.00 Mn |
| Dec 31, 2016 | 890.00 Mn |
| Dec 31, 2015 | 894.00 Mn |
| Jun 30, 2015 | 894.00 Mn |
| Dec 31, 2014 | 56.10 Mn |
| Sep 30, 2014 | 184.00 Mn |
| Jun 28, 2014 | 184.00 Mn |
| Mar 31, 2014 | 17.90 Mn |
| Dec 31, 2013 | 61.70 Mn |
| Sep 28, 2013 | 185.00 Mn |
| Jun 29, 2013 | 30.10 Mn |
| Mar 31, 2013 | 18.10 Mn |
| Dec 31, 2012 | 80.40 Mn |
| Sep 29, 2012 | 64.90 Mn |
| Jun 30, 2012 | 50.20 Mn |
| Mar 31, 2012 | 17.80 Mn |
| Dec 31, 2011 | 191.00 Mn |
| Sep 30, 2011 | 49.60 Mn |
| Mar 31, 2011 | 14.90 Mn |
| Dec 31, 2010 | 191.00 Mn |
| Mar 31, 2010 | 20.50 Mn |
| Dec 31, 2009 | 190.00 Mn |
| Sep 30, 2009 | 39.00 Mn |
| Jun 30, 2009 | 24.50 Mn |
| Mar 31, 2009 | 14.50 Mn |